PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who speak English
- People who have experienced actual or threatened sexual violence during military service (from the Vietnam era through to more recent conflicts including Operation Iraqi Freedom, Operation Enduring Freedom, and Operation New Dawn)
- People who have been diagnosed with PTSD as a result of military sexual trauma, with a symptom score above a certain level (above 40 on a clinical scale called the CAPS)
- People who are medically stable at the time of joining the study, including those with ongoing injuries or disabilities, as long as those conditions do not prevent attending weekly outpatient therapy sessions
- People who are able to give informed consent and have the ability to understand and complete all study assessments
- People who have been on the same psychiatric medications for at least 60 days before joining the study
Who may not be able to join:
- People who have ever been diagnosed with, or currently have, schizophrenia, another psychotic disorder, or bipolar disorder
- People who have taken part in another clinical trial or been receiving a formal evidence-based treatment for PTSD or military sexual trauma-related mental health conditions within the past 3 months
- People who have a significant unstable medical condition or brain-related impairment that would prevent them from attending sessions regularly or completing assessments
- People who, in the opinion of the trial investigator, currently present a risk of harm to themselves or others
- People who have had a substance dependence problem in the past 90 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: JoAnn Difede, PhD, Weill Medical College of Cornell University
Phone: 212-821-0783
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in mean Clinician Administered PTSD Scale-5 (CAPS-5) score changes between the Exposure Therapy (ET) and Interpersonal Psychotherapy (IPT) treatment groups from baseline to post-treatment; Change in CAPS-5 scores from baseline to post-treatment for the ET treatment group; Change in CAPS-5 scores from baseline to post-treatment for the IPT treatment group
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.